Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

Tumor organoids: applications in cancer modeling and potentials in precision medicine
Hanxiao Xu, Dechao Jiao, Aiguo Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 129
Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 60
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa T. Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 37
Oncolytic viruses: challenges and considerations in an evolving clinical landscape
Ulrich M. Lauer, Julia Beil
Future Oncology (2022) Vol. 18, Iss. 24, pp. 2713-2732
Open Access | Times Cited: 45
Oncolytic virotherapy in cancer treatment: challenges and optimization prospects
Lingjuan Chen, Mengsi Zuo, Qin Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 13
Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
Ji Wang, Chao Chen, Lu Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 32
Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option
Yi Ren, Jia-Meng Miao, Yuan-yuan Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Cancer immunotherapies: A hope for the uncurable?
Firas Hamdan, Vincenzo Cerullo
Frontiers in Molecular Medicine (2023) Vol. 3
Open Access | Times Cited: 17
Cancer organoids: A platform in basic and translational research
Xin Ma, Qin Wang, Guozheng Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 614-632
Open Access | Times Cited: 16
Immune landscape and response to oncolytic virus-based immunotherapy
Chaolong Lin, Wenzhong Teng, Tian Yang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 411-429
Closed Access | Times Cited: 5
Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment
Sara Feola, Salvatore Russo, Erkko Ylösmäki, et al.
Pharmacology & Therapeutics (2021) Vol. 236, pp. 108103-108103
Open Access | Times Cited: 37
Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma
Ghazaal Roozitalab, Behnaz Abedi, Saber İmani, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 889-918
Closed Access | Times Cited: 4
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model
Moritz Klawitter, Ali El-Ayoubi, Jasmin Buch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9965-9965
Open Access | Times Cited: 18
Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner
Miao Zeng, Wei Zhang, Yisheng Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Organoid co‐culture models of the tumor microenvironment promote precision medicine
Zhaoru Gu, Quanyou Wu, Bingqing Shang, et al.
Cancer Innovation (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
Wei Zhang, Xiaoqiang Zheng
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Current development in adenoviral vectors for cancer immunotherapy
Greyson Biegert, Amanda Rosewell Shaw, Masataka Suzuki
Molecular Therapy — Oncolytics (2021) Vol. 23, pp. 571-581
Open Access | Times Cited: 15
Oncolytic adenovirus-mediated dual knockdown of survivin and OCT4 improves therapeutic efficacy in esophageal cancer
Chun Guang Li, Maoling Zhu, Qijue Lu, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 5, pp. 193-193
Open Access | Times Cited: 5
Personalizing Oncolytic Virotherapy
Firas Hamdan, Manlio Fusciello, Vincenzo Cerullo
Human Gene Therapy (2023) Vol. 34, Iss. 17-18, pp. 870-877
Closed Access | Times Cited: 5
Translational Aspects of Epithelioid Sarcoma: Current Consensus
Thomas G. P. Grünewald, Sophie Postel‐Vinay, Robert Nakayama, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 6, pp. 1079-1092
Open Access | Times Cited: 5
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors
Sara Feola, Firas Hamdan, Salvatore Russo, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008342-e008342
Open Access | Times Cited: 1
Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer
Thai Q. Tran, Jeff Grein, Mohammed Selman, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200807-200807
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top